Barrier lipids used in moisturisers to support a comfortable, less reactive-feeling skin surface.
More on this ingredient: read the guide.
Read the neutral reference entry →The standard pairing for getting through retinisation. Ceramides support the barrier the retinoid is temporarily stressing; applying a ceramide moisturiser before or after the retinoid is the buffering approach dermatologists recommend.
Both support barrier function by different routes — niacinamide signals for more of the skin's own lipids, ceramides supply them directly. They appear together in barrier-repair formulas for exactly that reason.
Exfoliation on the nights you use it, barrier support after. Ceramides do not neutralise an AHA — they replace what aggressive exfoliation depletes, which is why they belong in the same routine rather than in a separate one.
A sensible counterweight. Salicylic acid clears the follicle and can dry the surface; a ceramide moisturiser afterwards keeps that drying from tipping into a compromised barrier.
Benzoyl peroxide is among the more drying acne actives, and ceramide moisturisers are the usual way to make it tolerable. Formulators commonly advise the pairing; the ceramides are there to offset irritation, not to boost the treatment.
The textbook humectant-plus-lipid combination: hyaluronic acid brings water to the surface, ceramides help hold it there. Hyaluronic acid on damp skin, the ceramide cream over the top.
Both are barrier-support lipids and they are routinely formulated together. Nothing to separate; this is the moisturising end of a routine rather than a combination to manage.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
We have not reviewed this combination. That means we have nothing to report about it — not that it is safe, and not that it is a problem. Treat it as an open question: introduce one new product at a time and patch-test, as you would with any unfamiliar pairing.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.